Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Liabilities and Shareholders Equity: 2017-2020

Historic Liabilities and Shareholders Equity for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to $250.9 million.

  • Cogent Biosciences' Liabilities and Shareholders Equity rose 53.99% to $215.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $932.4 million, marking a year-over-year increase of 259.61%. This contributed to the annual value of $250.9 million for FY2020, which is 407.69% up from last year.
  • As of FY2020, Cogent Biosciences' Liabilities and Shareholders Equity stood at $250.9 million, which was up 407.69% from $49.4 million recorded in FY2019.
  • Cogent Biosciences' 5-year Liabilities and Shareholders Equity high stood at $250.9 million for FY2020, and its period low was $49.1 million during FY2017.
  • Moreover, its 3-year median value for Liabilities and Shareholders Equity was $85.9 million (2018), whereas its average is $128.8 million.
  • As far as peak fluctuations go, Cogent Biosciences' Liabilities and Shareholders Equity plummeted by 42.48% in 2019, and later spiked by 407.69% in 2020.
  • Over the past 4 years, Cogent Biosciences' Liabilities and Shareholders Equity (Yearly) stood at $49.1 million in 2017, then spiked by 74.95% to $85.9 million in 2018, then plummeted by 42.48% to $49.4 million in 2019, then skyrocketed by 407.69% to $250.9 million in 2020.